Efficacy of Oral nutraceutical as adjunct to arthrocentesis -iPRF in Temporomandibular joint derangements - A RandomizedControl Trial - NI

Vaibhav Alone0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1. Patients who have given written informed consent to be a part of the study.
•2. Adult patients of either sex Age 18-60 years
•3. ASA I or ll
•4.Patients with Wilkes classification of Internal Derangement stage III and stage IV only with positive Mahan

•1. Age <18 years and >60 years
•2. Pregnant or lactating female
•3. Patients with severe debilitating conditions such as uncontrolled diabetes mellitus, uncontrolled hypertension,
•cardio respiratory conditions, previous history of cerebrovascular accidents, myocardial infarction, coronary
•artery disease, impaired renal and hepatic function and coagulation disorders
•4.Patients on antiplatelet/anticoagulant therapy.
•5.autoimmune diseases affecting joints
•6.Significant mechanical obstruction that prevents mouth opening,
•7.Acute capsulitis , synovitis
•8.Benign or malignant temporomandibular joint lesions,
•9.Neurological disorders

发起方

Vaibhav Alone